Over-the-counter monograph Skin & aging

Bacitracin

Bacitracin is a polypeptide antibiotic. It is filed in this library under skin & aging, a navigation topic rather than a statement of where it acts. As a regulatory matter it is sold over the counter under an FDA monograph and was never approved through a new drug application.

Regulatory status

Bacitracin is sold over the counter under an FDA monograph.

Monograph products are legally marketed without going through the new drug approval process, so 'FDA-approved' is not the right description.

The evidence

What has actually been published

One source on Bacitracin, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on skin & aging

Start with your own numbers.

Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.

See the OPTML Score

Educational reference only. This page explains what has been published about Bacitracin. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides